460
Views
1
CrossRef citations to date
0
Altmetric
Clinical Issues

What does the Dementia Rating Scale-2 measure? The relationship of neuropsychological measures to DRS-2 total and subscale scores in non-demented individuals with Parkinson’s disease

ORCID Icon, , , & ORCID Icon
Pages 174-193 | Received 31 May 2021, Accepted 24 Oct 2021, Published online: 15 Nov 2021

References

  • Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., & Kragh-Sørensen, P. (2003a). Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Archives of Neurology, 60(3), 387–392. https://doi.org/10.1001/archneur.60.3.387
  • Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K. (2000). Predictors of nursing home placement in Parkinson’s disease: A population‐based, prospective study. Journal of the American Geriatrics Society, 48(8), 938–942.
  • Aarsland, D., Litvan, I., Salmon, D., Galasko, D., Wentzel-Larsen, T., & Larsen, J. P. (2003b). Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 74(9), 1215–1220. https://doi.org/10.1136/jnnp.74.9.1215
  • Aita, S. L., Beach, J. D., Taylor, S. E., Borgogna, N. C., Harrell, M. N., & Hill, B. D. (2019). Executive, language, or both? An examination of the construct validity of verbal fluency measures. Applied Neuropsychology: Adult, 26(5), 441–451. https://doi.org/10.1080/23279095.2018.1439830
  • Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck depression inventory-II. San Antonio, 78(2), 490–498.
  • Benton, A. L., Sivan, A. B., Des Hamsher, K., Varney, N. R., & Spreen, O. (1994). Contributions to neuropsychological assessment (2nd ed.). Oxford University Press.
  • Benton, A. L., & Van Allen, M. W. (1968). Impairment in facial recognition in patients with cerebral disease. Transactions of the American Neurological Association, 93, 38–42.
  • Bezdicek, O., Michalec, J., Nikolai, T., Havránková, P., Roth, J., Jech, R., & Růžička, E. (2015). Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson’s disease and normative data. Dementia and Geriatric Cognitive Disorders, 39(5–6), 303–311.
  • Biundo, R., Formento-Dojot, P., Facchini, S., Vallelunga, A., Ghezzo, L., Foscolo, L., Meneghello, F., & Antonini, A. (2011). Brain volume changes in Parkinson’s disease and their relationship with cognitive and behavioural abnormalities. Journal of the Neurological Sciences, 310(1–2), 64–69.
  • Bobholz, J. H., & Brandt, J. (1993). Assessment of cognitive impairment: Relationship of the Dementia Rating Scale to the Mini-Mental State Examination. Journal of Geriatric Psychiatry and Neurology, 6(4), 210–213.
  • Brandt, J., & Benedict, R. H. B. (2001). Hopkins Verbal Learning Test—Revised, professional manual. Psychological Assessment Resources.
  • Brown, G. G., Rahill, A. A., Gorell, J. M., McDonald, C., Brown, S. J., Sillanpaa, M., & Shults, C. (1999). Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson’s disease. Journal of Geriatric Psychiatry and Neurology, 12(4), 180–188.
  • Carlson, K. D., & Herdman, A. O. (2012). Understanding the impact of convergent validity on research results. Organizational Research Methods, 15(1), 17–32. https://doi.org/10.1177/1094428110392383
  • Chase, T. N., Foster, N. L., Fedio, P., Brooks, R., Mansi, L., & di Chiro, G. (1984). Regional cortical dysfunction in Alzheimer’s disease as determined by positron emission tomography. Annals of Neurology, 15(S1), 170–174. https://doi.org/10.1002/ana.410150732
  • Cohen, J. (1988). Statistical power analysis for the behavioral 698 sciences. In Statistical Power Analysis for the Behavioral Sciences (2nd ed., Vol. 567, p. 495).
  • den Brok, M. G., van Dalen, J. W., van Gool, W. A., Moll van Charante, E. P., de Bie, R. M., & Richard, E. (2015). Apathy in Parkinson’s disease: A systematic review and meta‐analysis. Movement Disorders : Official Journal of the Movement Disorder Society, 30(6), 759–769.
  • Dissanayaka, N. N. W., Sellbach, A., Matheson, S., O’Sullivan, J. D., Silburn, P. A., Byrne, G. J., Marsh, R., & Mellick, G. D. (2010). Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Movement Disorders: official Journal of the Movement Disorder Society, 25(7), 838–845. https://doi.org/10.1002/mds.22833.
  • Dissanayaka, N. N., Torbey, E., & Pachana, N. A. (2015). Anxiety rating scales in Parkinson’s disease: A critical review updating recent literature. International Psychogeriatrics, 27(11), 1777–1784.
  • Elgh, E., Domellöf, M., Linder, J., Edström, M., Stenlund, H., & Forsgren, L. (2009). Cognitive function in early Parkinson’s disease: A population‐based study. European Journal of Neurology, 16(12), 1278–1284.
  • Emery, V. O. B., Gillie, E. X., & Smith, J. A. (1996). Reclassification of the vascular dementias: Comparisons of infarct and noninfarct vascular dementias. International Psychogeriatrics, 8(1), 33–61.
  • Fahn, S., & Elton, R. L. (1987). Members of the UPDRS Development Committee. Unified Parkinson’s disease rating scale. In S. Fahn, C. D. Marsden, D. Calne, & N. Holstein (Eds.), Recent developments in Parkinson’s disease (Vol. 2, pp. 153–163). Macmillian Healthcare Information.
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)90026-6
  • Gallagher, C., Bell, B., Bendlin, B., Palotti, M., Okonkwo, O., Sodhi, A., Wong, R., Buyan-Dent, L., Johnson, S., Wilette, A., Harding, S., Ninman, N., Kastman, E., & Alexander, A. (2013). White matter microstructural integrity and executive function in Parkinson’s disease. Journal of the International Neuropsychological Society, 19(3), 349–354. https://doi.org/10.1017/S1355617712001373
  • Golden, C. J. (1978). Stroop Color and Word Test: A manual for clinical and experimental uses. Stoelting Company.
  • Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M., & Morris, J. G. (2008). The Sydney multicenter study of Parkinson’s disease: The inevitability of dementia at 20 years. Movement Disorders : Official Journal of the Movement Disorder Society, 23(6), 837–844.
  • Higginson, C. I., King, D. S., Levine, D., Wheelock, V. L., Khamphay, N. O., & Sigvardt, K. A. (2003). The relationship between executive function and verbal memory in Parkinson’s disease. Brain and Cognition, 52(3), 343–352.
  • Hoehn, M. M., & Yahr, M. D. (1998). Parkinsonism: Onset, progression, and mortality. Neurology, 50(2), 318–318. https://doi.org/10.1212/WNL.50.2.318
  • Hughes, T. A., Ross, H. F., Mindham, R. H. S., & Spokes, E. G. S. (2004). Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurologica Scandinavica, 110(2), 118–123.
  • Jones, J. D., Hass, C., Mangal, P., Lafo, J., Okun, M. S., & Bowers, D. (2014). The Cognition and Emotional Well-being indices of the Parkinson’s disease questionnaire-39: What do they really measure? Parkinsonism & Related Disorders, 20(11), 1236–1241.
  • Jurica, P. J., Leitten, C. L., & Mattis, S. (2001). Dementia rating Scale-2: DRS-2: Professional manual. Psychological Assessment Resources.
  • Kaplan, E., Goodglass, H., & Weintraub, S. (1983). Boston Naming Test. Lea & Febiger.
  • Kenney, L., Rohl, B., Lopez, F. V., Lafo, J. A., Jacobson, C., Okun, M. S., Foote, K. D., & Bowers, D. (2020). The UF Deep Brain Stimulation Cognitive Rating Scale (DBS-CRS): Clinical decision making, validity, and outcomes. Frontiers in Human Neuroscience, 14, 578216. https://doi.org/10.3389/fnhum.2020.578216
  • Kessler, H. R., Roth, D. L., Kaplan, R. F., & Goode, K. T. (1994). Confirmatory factor analysis of the mattis dementia rating scale. Clinical Neuropsychologist, 8(4), 451–461. https://doi.org/10.1080/13854049408402047
  • Knox, M. R., Lacritz, L. H., Chandler, M. J., & Cullum, C. M. (2003). Association between Dementia Rating Scale performance and neurocognitive domains in Alzheimer’s disease. The Clinical Neuropsychologist, 17(2), 216–219. https://doi.org/10.1076/clin.17.2.216.16496
  • Kudlicka, A., Clare, L., & Hindle, J. V. (2011). Executive functions in Parkinson’s disease: Systematic review and meta‐analysis. Movement Disorders : Official Journal of the Movement Disorder Society, 26(13), 2305–2315.
  • Leentjens, A. F. G., Dujardin, K., Marsh, L., Martinez-Martin, P., Richard, I. H., Starkstein, S. E., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., Stebbins, G. T., & Goetz, C. G. (2008). Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Movement Disorders : official Journal of the Movement Disorder Society, 23(14), 2004–2014. https://doi.org/10.1002/mds.22229
  • Leentjens, A. F., Verhey, F. R., Luijckx, G. J., & Troost, J. (2000). The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson’s disease. Movement Disorders, 15(6), 1221–1224. https://doi.org/10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H
  • Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams-Gray, C. H., Aarsland, D., Kulisevsky, J., Rodriguez-Oroz, M. C., Burn, D. J., Barker, R. A., & Emre, M. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders : Official Journal of the Movement Disorder Society, 27(3), 349–356.
  • Lopez, F. V., Split, M., Filoteo, J. V., Litvan, I., Moore, R. C., Pirogovsky-Turk, E., Liu, L., Lessig, S., & Schiehser, D. M. (2018). Does the Geriatric Depression Scale measure depression in Parkinson’s disease? International Journal of Geriatric Psychiatry, 33(12), 1662–1670. https://doi.org/10.1002/gps.4970
  • Lucas, J. A., Ivnik, R. J., Smith, G. E., Bohac, D. L., Tangalos, E. G., Kokmen, E., Graff-Radford, N. R., & Petersen, R. C. (1998). Normative data for the Mattis dementia rating scale. Journal of Clinical and Experimental Neuropsychology, 20(4), 536–547.
  • Marson, D. C., Dymek, M. P., Duke, L. W., & Harrell, L. E. (1997). Subscale validity of the mattis dementia rating scale. Archives of Clinical Neuropsychology : The Official Journal of the National Academy of Neuropsychologists, 12(3), 269–275.
  • Massman, P. J., Delis, D. C., Butters, N., Levin, B. E., & Salmon, D. P. (1990). Are all subcortical dementias alike?: Verbal learning and memory in Parkinson’s and Huntington’s disease patients. Journal of Clinical and Experimental Neuropsychology, 12(5), 729–744.
  • Matteau, E., Dupré, N., Langlois, M., Provencher, P., & Simard, M. (2012). Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia. Journal of Geriatric Psychiatry and Neurology, 25(2), 100–106. https://doi.org/10.1177/0891988712445086
  • Mattis, S. (1988). Dementia Rating Scale. Psychological Assessment Resources.
  • McKinlay, A., Grace, R. C., Dalrymple-Alford, J. C., & Roger, D. (2009). Cognitive characteristics associated with mild cognitive impairment in Parkinson’s disease. Dementia and Geriatric Cognitive Disorders, 28(2), 121–129.
  • Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65(8), 1239–1245.
  • Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699.
  • Noe, E., Marder, K., Bell, K. L., Jacobs, D. M., Manly, J. J., & Stern, Y. (2004). Comparison of dementia with Lewy bodies to Alzheimer’s disease and Parkinson’s disease with dementia. Movement Disorders, 19(1), 60–67. https://doi.org/10.1002/mds.10633
  • Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015). Apathy in Parkinson’s disease: Clinical features, neural substrates, diagnosis, and treatment. The Lancet. Neurology, 14(5), 518–531.
  • Paolo, A. M., Tröster, A. I., Glatt, S. L., Hubble, J. P., & Koller, W. C. (1995). Differentiation of the dementias of Alzheimer’s and Parkinson’s disease with the dementia rating scale. Journal of Geriatric Psychiatry and Neurology, 8(3), 184–188.
  • Pirogovsky, E., Schiehser, D. M., Litvan, I., Obtera, K. M., Burke, M. M., Lessig, S. L., Song, D. D., Liu, L., & Filoteo, J. V. (2014). The utility of the Mattis Dementia Rating Scale in Parkinson’s disease mild cognitive impairment. Parkinsonism & Related Disorders, 20(6), 627–631.
  • Ratajska, A. M., Lopez, F. V., Kenney, L., Jacobson, C., Foote, K. D., Okun, M. S., & Bowers, D. (2021). Cognitive subtypes in individuals with essential tremor seeking deep brain stimulation. The Clinical Neuropsychologist, 1–23. Advance online publication. https://doi.org/10.1080/13854046.2021.1882578
  • Reijnders, J. S., Ehrt, U., Weber, W. E., Aarsland, D., & Leentjens, A. F. (2008). A systematic review of prevalence studies of depression in Parkinson’s disease. Movement Disorders : Official Journal of the Movement Disorder Society, 23(2), 183–189.
  • Reitan, R. M. (1992). Trail Making Test: Manual for administration and scoring. Reitan Neuropsychology Laboratory.
  • Salmon, D. P., Kwo-On-Yuen, P. F., Heindel, W. C., Butters, N., &Thal, L. & J, (1989). Differentiation of Alzheimer’s disease and Huntington’s disease with the Dementia Rating Scale. Archives of Neurology, 46(11), 1204–1208.
  • Schmidt, K. S. (2004). Dementia Rating Scale-2 alternate form: Manual supplement. Psychological Assessment Resources.
  • Scott, B. M., Eisinger, R. S., Burns, M. R., Lopes, J., Okun, M. S., Gunduz, A., & Bowers, D. (2020). Co-occurrence of apathy and impulse control disorders in Parkinson disease. Neurology, 95(20), e2769–e2780.
  • Siepel, F. J., Brønnick, K. S., Booij, J., Ravina, B. M., Lebedev, A. V., Pereira, J. B., Grüner, R., & Aarsland, D. (2014). Cognitive executive impairment and dopaminergic deficits in de novo Parkinson’s disease. Movement Disorders : Official Journal of the Movement Disorder Society, 29(14), 1802–1808. https://doi.org/10.1002/mds.26051
  • Skorvanek, M., Goldman, J. G., Jahanshahi, M., Marras, C., Rektorova, I., Schmand, B., van Duijn, E., Goetz, C. G., Weintraub, D., Stebbins, G. T., Martinez-Martin, P., & members of the MDS Rating Scales Review Committee. (2018). Global scales for cognitive screening in Parkinson’s disease: Critique and recommendations. Movement Disorders : Official Journal of the Movement Disorder Society, 33(2), 208–218.
  • Smith, G. E., Ivnik, R. J., Malec, J. F., Kokmen, E., Tangalos, E., & Petersen, R. C. (1994). Psychometric properties of the mattis dementia rating scale. Assessment, 1(2), 123–131. https://doi.org/10.1177/1073191194001002002
  • Spielberger, C. D., Gorsuch, R. L., Lushene, R. E., Vagg, P. R., & Jacobs, G. A. (1970). Manual for the state-trait inventory. Consulting Psychologists.
  • Starkstein, S. E., Mayberg, H. S., Preziosi, T., Andrezejewski, P., Leiguarda, R., & Robinson, R. G. (1992). Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 4(2), 134–139.
  • Strauss, E., Sherman, E. M., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms, and commentary. American Chemical Society.
  • Tombaugh, T. N., Kozak, J., & Rees, L. (1999). Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Archives of Clinical Neuropsychology : The Official Journal of the National Academy of Neuropsychologists, 14(2), 167–177.
  • Torbey, E., Pachana, N. A., & Dissanayaka, N. N. (2015). Depression rating scales in Parkinson’s disease: A critical review updating recent literature. Journal of Affective Disorders, 184, 216–224.
  • Villeneuve, S., Rodrigues-Brazète, J., Joncas, S., Postuma, R. B., Latreille, V., & Gagnon, J. F. (2011). Validity of the Mattis Dementia Rating Scale to detect mild cognitive impairment in Parkinson’s disease and REM sleep behavior disorder. Dementia and Geriatric Cognitive Disorders, 31(3), 210–217.
  • Wechsler, D. (1997). The Wechsler Memory Scale (3rd ed.). Psychological Corporation.
  • Whiteside, D. M., Kealey, T., Semla, M., Luu, H., Rice, L., Basso, M. R., & Roper, B. (2016). Verbal fluency: Language or executive function measure? Applied Neuropsychology. Adult, 23(1), 29–34. https://doi.org/10.1080/23279095.2015.1004574
  • Woodard, J. L., Salthouse, T. A., Godsall, R. E., & Green, R. C. (1996). Confirmatory factor analysis of the Mattis Dementia Rating Scale in patients with Alzheimer’s disease. Psychological Assessment, 8(1), 85–91. https://doi.org/10.1037/1040-3590.8.1.85
  • Woods, S. P., & Tröster, A. I. (2003). Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease. Journal of the International Neuropsychological Society : JINS, 9(1), 17–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.